N-benzhydryl-4-fluoroaniline | 1036451-67-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N-benzhydryl-4-fluoroaniline
• CAS: 1036451-67-8
• 化学式: C₁₉H₁₆FN
• 分子量: 277.341
• InChiKey: SBQUGYLIIZJUGX-UHFFFAOYSA-N

物化性质

• 沸点：
  392.2±30.0 °C(Predicted)
• 密度：
  1.167±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  5.2
• 重原子数：
  21
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.05
• 拓扑面积：
  12
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  二苯甲酮 在 六氟磷酸银 、 magnesium sulfate 、 一水合肼 、 溶剂黄146 作用下， 以 乙醇 、 二氯甲烷 为溶剂， 反应 19.17h， 生成 N-benzhydryl-4-fluoroaniline
  参考文献：
  名称：

  银催化的芳基/芳基重氮烷烃与苯胺的 N-H 官能化

  摘要：

  在此，我们报告了使用简单的 AgPF 6作为催化剂的伯和仲苯胺与二芳基重氮烷烃的 N-H 官能化反应。我们证明了二芳基重氮烷烃与不同苯胺反应的广泛适用性（31 个例子，产率高达 97%）。此外，我们提出了 N-H 官能化的可能反应机制。

  DOI：

  10.1021/acs.orglett.1c02289

文献信息

• General Synthesis of <i>N</i>-Alkylation of Amines with Secondary Alcohols via Hydrogen Autotransfer
  作者：Murugan Subaramanian、Siba P. Midya、Palmurukan M. Ramar、Ekambaram Balaraman

  DOI：10.1021/acs.orglett.9b02990

  日期：2019.11.15

  Direct catalytic N-alkylation of amines with secondary alcohols via hydrogen autotransfer (HA) strategy is very challenging and has been scarcely reported, even under precious metal catalysis. Herein, an efficient N-alkylation of amines, including benzylamines using secondary alcohols as alkylating agents, is reported. This reaction is catalyzed by a molecularly defined NNN-Ni(II) pincer complex, and

  通过氢自动转移（HA）策略将胺与仲醇直接催化N-烷基化非常具有挑战性，甚至在贵金属催化下也很少报道。本文中，报道了使用仲醇作为烷基化剂的胺（包括苄胺）的有效N-烷基化。该反应由分子定义的NNN-Ni（II）钳配合物催化，该反应在温和，良性的条件下进行。可以耐受各种底物和官能团。初步的机理研究表明，N-烷基化反应是通过氢自动转移机理进行的。
• Compounds, Methods And Devices for Inhibiting Neoproliferative Changes in Blood Vessel Walls
  申请人：Koehler Ralf

  公开号：US20090048270A1

  公开（公告）日：2009-02-19

  Methods, compositions and devices for inhibiting neoproliferative changes in blood vessel walls or other anatomical structures. One or more compounds of Formula I or I-A set forth herein are administered systemically and/or locally to human or veterinary patients to deter or prevent unwanted proliferative changes in blood vessels or other anatomical structures. The invention may be used to deter or prevent stenosis or restenosis of arteries following angioplasty and/or stent placement. In one embodiment, there is provided an implantable stent or stent graft from which one or more compounds of the present invention will elute or otherwise be delivered into an affected blood vessel wall.

  本发明提供了抑制血管壁或其他解剖结构中新生增生的方法、组合物和装置。本发明中的公式I或I-A中的一个或多个化合物被系统性和/或局部地用于人类或兽医患者，以防止或预防血管或其他解剖结构中不必要的增生变化。本发明可用于防止或预防血管成形术和/或支架置入后的动脉狭窄或再狭窄。在一种实施方式中，提供了一种可植入的支架或支架移植物，其中本发明的一个或多个化合物将被释放或以其他方式输送到受影响的血管壁中。
• Non-peptide inhibition of T-lymphocyte activation and therapies related thereto
  申请人：Chandy George K.

  公开号：US20070293554A1

  公开（公告）日：2007-12-20

  Compounds, preparations and methods for immunosuppressive treatment of autoimmune disorders, graft rejection and/or graft/host disease. Therapeutically effective amounts of certain substituted triarylmethane compounds, such as 1-[(2-chlorophenyl)diphenylmethyl]-1H-pyrazole, are administered to mammalian patients to selectively inhibit the calcium-activated K + channel (IKCa1) in lymphocytes, monocytes, macrophages, platelets or endothelial cells without concomitant inhibition of P450-dependent enzyme systems, resulting in reduction of antigen-, cytokine-, or mitogen-induced calcium entry through store operated calcium channels in these cells, suppression of cytokine production by these cells, and inhibition of activation of these cells. Such inhibition of the Ca ++ activated K + channel (IKCa1) prevents the pre-Ca ++ stage of cell activation and thus causes immunosuppression and an anti-inflammatory response.

  化合物、制剂和方法用于免疫抑制治疗自身免疫性疾病、移植排斥和/或移植宿主病。将某些取代三芳基甲烷化合物，例如1-[(2-氯苯基)二苯甲基]-1H-吡唑酮，以治疗剂量给哺乳动物患者，以选择性抑制淋巴细胞、单核细胞、巨噬细胞、血小板或内皮细胞中的钙激活K+通道（IKCa1），而不伴随P450依赖性酶系统的抑制，从而减少这些细胞中抗原、细胞因子或诱导剂引起的钙离子进入，抑制这些细胞的细胞因子产生，并抑制这些细胞的激活。这种对Ca++激活的K+通道（IKCa1）的抑制防止了细胞激活的前Ca++阶段，从而引起免疫抑制和抗炎反应。
• Copper Acetoacetonate [Cu(acac)₂]/BINAP-Promoted C<i>sp</i>³N Bond Formation<i>via</i>Reductive Coupling of<i>N</i>-Tosylhydrazones with Anilines
  作者：Jessy Aziz、Jean-Daniel Brion、Abdallah Hamze、Mouad Alami

  DOI：10.1002/adsc.201300466

  日期：2013.8.12

  AbstractWe report the the copper(II) acetoacetonate [Cu(acac)2]/BINAP‐catalyzed synthesis of arylamines from N‐tosylhydrazones and anilines. A fine tuning of the reaction conditions was required to accomplish the cross‐coupling successfully, including the ligands effect and the addition of small amounts of water. The characteristic feature of this protocol is its functional group compatibility and its chemoselectivity when various aminophenol derivatives were used. Taking into consideration the interest for this copper‐reductive coupling in which no stoichiometric metal hydride reagent is employed, this can be considered as an alternative to the conventional reductive amination.magnified image
• US6803375B1
  申请人：——

  公开号：US6803375B1

  公开（公告）日：2004-10-12